An observational study in HIV/AIDS, sponsored by Harvard School of Public Health (HSPH). Completed at 9 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-06-27.
Sponsored by Harvard School of Public Health (HSPH) · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Acquired Immunodeficiency Syndrome by Harvard School of Public Health (HSPH) — none open to participants now, none under way, none of them phase 3. Acquired Immunodeficiency Syndrome · Harvard School of Public Health (HSPH).
Among the 13 studies in Acquired Immunodeficiency Syndrome by Harvard School of Public Health (HSPH), this one is the only one that started in 2017, is one of 3 observational ones, and was the 12th registered.
3,037 studies on the registry are indexed under Acquired Immunodeficiency Syndrome; 307 are open to participants now.
Browse Acquired Immunodeficiency Syndrome studies →None of the 13 studies in Acquired Immunodeficiency Syndrome by Harvard School of Public Health (HSPH) is open now. The open studies under Acquired Immunodeficiency Syndrome, anywhere →
Of the 198 Acquired Immunodeficiency Syndrome studies recruiting now, 118 (60%) set no upper age limit and 67 (34%) stop at 75 or younger; 43 take children under 18; 68 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2002; this study’s year is marked. 1 started in 2017.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 334 is above the median of 289 across 504 observational studies indexed under Acquired Immunodeficiency Syndrome.
Median enrollment 597 across the 10 interventional studies, 678 across the 3 observational. Of the 13 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Harvard School of Public Health (HSPH) is the lead sponsor of 154 studies on the registry; 10 are open to participants now.
None of the studies under way reaches primary completion within a year.
Among the 13 studies in Acquired Immunodeficiency Syndrome by Harvard School of Public Health (HSPH), from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This is a prospective cohort study designed to define the impact of HIV infection and antiretroviral therapy (ART) on young adults with perinatal HIV infection as they transition to adulthood.
This is a prospective cohort study designed to define the impact of HIV infection and antiretroviral therapy (ART) on young adults with perinatal HIV infection as they transition to adulthood.
The primary objectives of this study are:
Perinatally HIV-infected (PHIV+) young adults 18 years of age or older at the time of enrollment born to HIV-infected mothers.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
HIV
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Perinatally HIV-infected participants at or beyond their 18th birthday at enrollment.
HIV Disease Progression
Factors of interest for this outcome include virologic suppression, immune impairment, immune activation, changes in ART, cumulative exposure to specific ART, viral resistance, co-infections, and host genetic polymorphisms. Data will be collected through chart abstraction.
Time frame: Annually for 6 years
Metabolic Anomalies
Data will be collected by chart review, physical assessments, and laboratory evaluations.
Time frame: Annually for 6 years
Sexually Transmitted Infections
Data collected through chart abstraction.
Time frame: Annually for 6 years
Reproductive Health
Data collected through an online surveys and chart abstraction.
Time frame: Annually for 6 years
Mental Health
Data collected through an online survey and chart abstraction.
Time frame: Annually for 6 years.
ART Adherence
Data collected through an online survey.
Time frame: Annually for 6 years
Risk Behaviors (Sexual and Substance Use)
Data collected through an online survey.
Time frame: Annually for 6 years
Transition to Adult Functioning
Data collected through an online survey.
Time frame: Annually for 6 years.
Hearing Dysfunction
Data collected through an online survey and chart abstraction.
Time frame: Annually for 6 years.
Ran from Nov 2017 to primary completion in May 2025, 90 months.
Of 165 non-industry observational studies under Acquired Immunodeficiency Syndrome, half reached primary completion within 46 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 83. This study's 90 months is above that.
Counting every sponsor, half of 177 studies reached it within 44 months; a quarter within 19 and three quarters within 79.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Acquired Immunodeficiency Syndrome →
Harvard School of Public Health (HSPH) →